Safety, Efficacy, and Pharmacokinetics of Gremubamab (Medi3902), an Anti-Pseudomonas Aeruginosa Bispecific Human Monoclonal Antibody, in P. Aeruginosa-Colonised, Mechanically Ventilated Intensive Care Unit Patients: a Randomised Controlled Trial

AuthID
P-015-FDH
100
Author(s)
Chastre J.
·
François B.
·
Bourgeois M.
·
Komnos A.
·
Ferrer R.
·
Rahav G.
·
De Schryver N.
·
Lepape A.
·
Koksal I.
·
Luyt C.E.
·
[+74]·
[+6]·
Oteiza L.
·
Escudero D.
·
Piacentini E.
·
Vera P.
·
Tamayo L.
·
Gallego M.A.G.
·
Canas B.S.
·
Figueira I.
·
Leon R.
Document Type
Article
Year published
2022
Published
in Critical Care, ISSN: 1364-8535
Volume: 26, Issue: 1
Indexing
Publication Identifiers
Pubmed: 36380312
Scopus: 2-s2.0-85141978555
Source Identifiers
ISSN: 1364-8535
Export Publication Metadata
Marked List
Citations
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.



CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Info
At this moment we don't have any links to full text documens.
Name Order Name   Name Order Name   Name Order Name
1 Chastre J.;   2 François B.;   3 Bourgeois M.;
4 Komnos A.;   5 Ferrer R.;   6 Rahav G.;
7 De Schryver N.;   8 Lepape A.;   9 Koksal I.;
10 Luyt C.E.;   11 Sánchez-García M.;   12 Torres A.;
13 Eggimann P.;   14 Koulenti D.;   15 Holland T.L.;
16 Ali O.;   17 Shoemaker K.;   18 Ren P.;
19 Sauser J.;   20 Ruzin A.;   21 Tabor D.E.;
22 Akhgar A.;   23 Wu Y.;   24 Jiang Y.;
25 DiGiandomenico A.;   26 Colbert S.;   27 Vandamme D.;
28 Coenjaerts F.;   29 Malhotra-Kumar S.;   30 Timbermont L.;
31 Oliver A.;   32 Barraud O.;   33 Bellamy T.;
34 Bonten M.;   35 Goossens H.;   36 Reisner C.;
37 Esser M.T.;   38 Jafri H.S.;   39 Joannidis M.;
40 Klimscha W.;   41 De Waele E.;   42 Devriendt J.;
43 Huberlant V.;   44 Depuydt P.;   45 Van Boxstael S.;
46 Peric M.;   47 Kopic J.;   48 Hanauer M.;
49 Hruby T.;   50 Sramek V.;   51 Svoboda P.;
52 Vymazal T.;   53 Novacek M.;   54 Annane D.;
55 Mira J.P.;   56 Souweine B.;   57 Dequin P.F.;
58 Meziani F.;   59 Stephan F.;   60 Nseir S.;
61 Gibot S.;   62 Schwebel C.;   63 Plantefeve G.;
64 Diehl J.L.;   65 Richard C.;   66 Lamer C.;
67 Klouche K.;   68 Jaber S.;   69 Zakynthinos E.;
70 Filntisis G.;   71 Zakynthinos S.;   72 Koutsoukou A.;
73 Saroglou G.;   74 Nikolaou C.;   75 Vlachogianni G.;
76 Pnevmatikos I.;   77 Mandragos K.;   78 Kremer I.;
79 Rozgonyi Z.D.;   80 Marjanek Z.;   81 Martin-Loeches I.;
82 Singer P.;   83 Van Heerden V.;   84 Carmeli Y.;
85 Povoa P. ;   86 Seoane A.A.;   87 Moura P.;
88 Gonzalez F.;   89 Ramirez P.;   90 Marti A.T.;
91 Roca R.F.;   92 Oteiza L.;   93 Escudero D.;
94 Piacentini E.;   95 Vera P.;   96 Tamayo L.;
97 Gallego M.A.G.;   98 Canas B.S.;   99 Figueira I.;
100 Leon R.;